Please enable JavaScript to continue using this application.

Compare $ENTA vs $FENC | Chartloom

Compare

$ENTA vs $FENC

Enanta Pharmaceuticals Inc · Fennec Pharmaceuticals Inc

ENTA

Enanta Pharmaceuticals Inc

FENC

Fennec Pharmaceuticals Inc

Compare $ENTA vs $FENC

Comparing Enanta Pharmaceuticals Inc and Fennec Pharmaceuticals Inc

ENTAEnanta Pharmaceuticals Inc

FENCFennec Pharmaceuticals Inc

ENTAEnanta Pharmaceuticals Inc

Market cap

$364M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.51x

Rev growth (TTM)

0.7%

YTD performance

-13.3%

52W performance

10.6%

FCF yield

-10.2%

FENCFennec Pharmaceuticals Inc

Market cap

$372M

P/E (TTM)

—

Forward P/E (NTM)

18.55x

Forward P/S (NTM)

4.23x

Rev growth (TTM)

77.8%

YTD performance

39.5%

52W performance

16.2%

FCF yield

-0.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ENTA

FENC

Detailed metrics comparison

ENTA

Enanta Pharmaceuticals Inc

FENC

Fennec Pharmaceuticals Inc

Market Cap

ENTA$364M

FENC$372M

Enterprise Value

ENTA$456M

FENC$331M

Price

ENTA$12.50

FENC$10.71

P/E Ratio

ENTAN/A

FENCN/A

P/S Ratio

ENTA5.57x

FENC6.28x

EV/Sales

ENTA6.99x

FENC5.59x

EV/EBITDA

ENTA31.83x

FENC111.97x

P/B Ratio

ENTA3.73x

FENC8.43x

P/FCF Ratio

ENTAN/A

FENCN/A

EV/FCF

ENTA-12.36x

FENC-162.16x

PEG Ratio

ENTAN/A

FENCN/A

Forward P/E (NTM)

ENTAN/A

FENC18.55x

Forward P/S (NTM)

ENTA6.51x

FENC4.23x

Revenue (TTM)

ENTA$65M

FENC$59M

Revenue Growth (YoY)

ENTA0.7%

FENC77.8%

Forward Rev Growth

ENTA-7.3%

FENC42.8%

Gross Margin (TTM)

ENTA0.0%

FENC93.7%

Operating Margin (TTM)

ENTA0.0%

FENC0.0%

EBITDA Margin (TTM)

ENTA-82.5%

FENC-1.9%

Net Margin (TTM)

ENTA-96.9%

FENC-5.5%

FCF Margin (TTM)

ENTA-56.6%

FENC-3.4%

Net Income (TTM)

ENTA$-63M

FENC$-3M

FCF (TTM)

ENTA$-37M

FENC$-2M

EPS (TTM)

ENTA-$2.17

FENC-$0.09

ROE (TTM)

ENTA-6184.0%

FENC-678.0%

ROA (TTM)

ENTA-2070.0%

FENC-486.0%

ROIC (TTM)

ENTA-2677.0%

FENC-678.0%

Cash

ENTA$33M

FENC$41M

Debt

ENTA$126M

FENC$0

Net Cash/Debt

ENTA$-93M

FENC$41M

Current Ratio (TTM)

ENTA3.76x

FENC5.85x

Quick Ratio (TTM)

ENTA3.62x

FENC5.36x

Debt/Equity (TTM)

ENTA1.25x

FENC0.00x

Debt/Assets (TTM)

ENTA0.0%

FENC0.0%

Interest Coverage (TTM)

ENTAN/A

FENCN/A

Net Debt/EBITDA (TTM)

ENTA0.00x

FENC0.00x

Beta

ENTA0.72

FENC1.21

52W Performance

ENTA10.6%

FENC16.2%

YTD Performance

ENTA-13.3%

FENC39.5%

% from 52W High

ENTA-27.1%

FENC-19.2%

% from 52W Low

ENTA22.5%

FENC89.6%

Asset Turnover (TTM)

ENTA0.21x

FENC0.89x

FCF Yield (TTM)

ENTA-10.2%

FENC-0.5%

Earnings Yield (TTM)

ENTA-17.4%

FENC-0.9%

Dividend Yield (TTM)

ENTAN/A

FENCN/A

Rule of 40

ENTA-55.9

FENC74.4

EV/GP/RG

ENTAN/A

FENC0.12

Ticker research

View ENTA research View FENC research

Metric	ENTA Enanta Pharmaceuticals Inc	FENC Fennec Pharmaceuticals Inc
Market & Valuation
Market Cap	$364M	$372M
Enterprise Value	$456M	$331M
Price	$12.50	$10.71
P/E Ratio	N/A	N/A
P/S Ratio	5.57x	6.28x
EV/Sales	6.99x	5.59x
EV/EBITDA	31.83x	111.97x
P/B Ratio	3.73x	8.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.36x	-162.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	18.55x
Forward P/S (NTM)	6.51x	4.23x
Revenue & Growth
Revenue (TTM)	$65M	$59M
Revenue Growth (YoY)	0.7%	77.8%
Forward Rev Growth	-7.3%	42.8%
Profitability
Gross Margin (TTM)	0.0%	93.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-82.5%	-1.9%
Net Margin (TTM)	-96.9%	-5.5%
FCF Margin (TTM)	-56.6%	-3.4%
Net Income (TTM)	$-63M	$-3M
FCF (TTM)	$-37M	$-2M
EPS (TTM)	-$2.17	-$0.09
ROE (TTM)	-6184.0%	-678.0%
ROA (TTM)	-2070.0%	-486.0%
ROIC (TTM)	-2677.0%	-678.0%
Financial Health
Cash	$33M	$41M
Debt	$126M	$0
Net Cash/Debt	$-93M	$41M
Current Ratio (TTM)	3.76x	5.85x
Quick Ratio (TTM)	3.62x	5.36x
Debt/Equity (TTM)	1.25x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.72	1.21
52W Performance	10.6%	16.2%
YTD Performance	-13.3%	39.5%
% from 52W High	-27.1%	-19.2%
% from 52W Low	22.5%	89.6%
Efficiency & Yields
Asset Turnover (TTM)	0.21x	0.89x
FCF Yield (TTM)	-10.2%	-0.5%
Earnings Yield (TTM)	-17.4%	-0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-55.9	74.4
EV/GP/RG	N/A	0.12
Ticker research	View ENTA research	View FENC research

Valuation

P/S Ratio

ENTA

5.57x

FENC

6.28x

EV/FCF

FENC

-162.16x

ENTA

-12.36x

Growth & revenue

Revenue Growth TTM

FENC

77.8%

ENTA

0.7%

Forward Revenue Growth

FENC

42.8%

ENTA

-7.3%

Profitability & performance

Gross Margin

FENC

93.7%

ENTA

0.0%

ROE

FENC

-678.0%

ENTA

-6184.0%

FCF Yield %

FENC

-0.5%

ENTA

-10.2%

52-Week Performance

FENC

16.2%

ENTA

10.6%

Detailed metrics comparison

ENTA

Enanta Pharmaceuticals Inc

FENC

Fennec Pharmaceuticals Inc

Market Cap

ENTA$364M

FENC$372M

Enterprise Value

ENTA$456M

FENC$331M

Price

ENTA$12.50

FENC$10.71

P/E Ratio

ENTAN/A

FENCN/A

P/S Ratio

ENTA5.57x

FENC6.28x

EV/Sales

ENTA6.99x

FENC5.59x

EV/EBITDA

ENTA31.83x

FENC111.97x

P/B Ratio

ENTA3.73x

FENC8.43x

P/FCF Ratio

ENTAN/A

FENCN/A

EV/FCF

ENTA-12.36x

FENC-162.16x

PEG Ratio

ENTAN/A

FENCN/A

Forward P/E (NTM)

ENTAN/A

FENC18.55x

Forward P/S (NTM)

ENTA6.51x

FENC4.23x

Revenue (TTM)

ENTA$65M

FENC$59M

Revenue Growth (YoY)

ENTA0.7%

FENC77.8%

Forward Rev Growth

ENTA-7.3%

FENC42.8%

Gross Margin (TTM)

ENTA0.0%

FENC93.7%

Operating Margin (TTM)

ENTA0.0%

FENC0.0%

EBITDA Margin (TTM)

ENTA-82.5%

FENC-1.9%

Net Margin (TTM)

ENTA-96.9%

FENC-5.5%

FCF Margin (TTM)

ENTA-56.6%

FENC-3.4%

Net Income (TTM)

ENTA$-63M

FENC$-3M

FCF (TTM)

ENTA$-37M

FENC$-2M

EPS (TTM)

ENTA-$2.17

FENC-$0.09

ROE (TTM)

ENTA-6184.0%

FENC-678.0%

ROA (TTM)

ENTA-2070.0%

FENC-486.0%

ROIC (TTM)

ENTA-2677.0%

FENC-678.0%

Cash

ENTA$33M

FENC$41M

Debt

ENTA$126M

FENC$0

Net Cash/Debt

ENTA$-93M

FENC$41M

Current Ratio (TTM)

ENTA3.76x

FENC5.85x

Quick Ratio (TTM)

ENTA3.62x

FENC5.36x

Debt/Equity (TTM)

ENTA1.25x

FENC0.00x

Debt/Assets (TTM)

ENTA0.0%

FENC0.0%

Interest Coverage (TTM)

ENTAN/A

FENCN/A

Net Debt/EBITDA (TTM)

ENTA0.00x

FENC0.00x

Beta

ENTA0.72

FENC1.21

52W Performance

ENTA10.6%

FENC16.2%

YTD Performance

ENTA-13.3%

FENC39.5%

% from 52W High

ENTA-27.1%

FENC-19.2%

% from 52W Low

ENTA22.5%

FENC89.6%

Asset Turnover (TTM)

ENTA0.21x

FENC0.89x

FCF Yield (TTM)

ENTA-10.2%

FENC-0.5%

Earnings Yield (TTM)

ENTA-17.4%

FENC-0.9%

Dividend Yield (TTM)

ENTAN/A

FENCN/A

Rule of 40

ENTA-55.9

FENC74.4

EV/GP/RG

ENTAN/A

FENC0.12

Ticker research

View ENTA research View FENC research

Metric	ENTA Enanta Pharmaceuticals Inc	FENC Fennec Pharmaceuticals Inc
Market & Valuation
Market Cap	$364M	$372M
Enterprise Value	$456M	$331M
Price	$12.50	$10.71
P/E Ratio	N/A	N/A
P/S Ratio	5.57x	6.28x
EV/Sales	6.99x	5.59x
EV/EBITDA	31.83x	111.97x
P/B Ratio	3.73x	8.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.36x	-162.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	18.55x
Forward P/S (NTM)	6.51x	4.23x
Revenue & Growth
Revenue (TTM)	$65M	$59M
Revenue Growth (YoY)	0.7%	77.8%
Forward Rev Growth	-7.3%	42.8%
Profitability
Gross Margin (TTM)	0.0%	93.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-82.5%	-1.9%
Net Margin (TTM)	-96.9%	-5.5%
FCF Margin (TTM)	-56.6%	-3.4%
Net Income (TTM)	$-63M	$-3M
FCF (TTM)	$-37M	$-2M
EPS (TTM)	-$2.17	-$0.09
ROE (TTM)	-6184.0%	-678.0%
ROA (TTM)	-2070.0%	-486.0%
ROIC (TTM)	-2677.0%	-678.0%
Financial Health
Cash	$33M	$41M
Debt	$126M	$0
Net Cash/Debt	$-93M	$41M
Current Ratio (TTM)	3.76x	5.85x
Quick Ratio (TTM)	3.62x	5.36x
Debt/Equity (TTM)	1.25x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.72	1.21
52W Performance	10.6%	16.2%
YTD Performance	-13.3%	39.5%
% from 52W High	-27.1%	-19.2%
% from 52W Low	22.5%	89.6%
Efficiency & Yields
Asset Turnover (TTM)	0.21x	0.89x
FCF Yield (TTM)	-10.2%	-0.5%
Earnings Yield (TTM)	-17.4%	-0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-55.9	74.4
EV/GP/RG	N/A	0.12
Ticker research	View ENTA research	View FENC research